Zeyong Jiang

Guangzhou, 510095, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Effects of S-ketamine added to patient-controlled analgesia on early postoperative pain and recovery in patients undergoing thoracoscopic lung surgery: A randomized double-blinded controlled trial.

Effects of S-ketamine added to patient-controlled analgesia on early postoperative pain and recovery in patients undergoing thoracoscopic lung surgery: A randomized double-blinded controlled trial.

Journal: Journal of clinical anesthesia
Published: May 26, 2023

Long intergenic non-protein-coding RNA 1547 acts as a competing endogenous RNA and exerts cancer-promoting activity in non-small cell lung cancer by targeting the microRNA-195-5p/ homeobox C8 axis.

Long intergenic non-protein-coding RNA 1547 acts as a competing endogenous RNA and exerts cancer-promoting activity in non-small cell lung cancer by targeting the microRNA-195-5p/ homeobox C8 axis.

Journal: Heliyon
Published: September 03, 2022

CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy.

CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy.

Journal: Archives of toxicology
Published: August 10, 2022

CircRNA PTPRM Promotes Non-Small Cell Lung Cancer Progression by Modulating the miR-139-5p/SETD5 Axis.

CircRNA PTPRM Promotes Non-Small Cell Lung Cancer Progression by Modulating the miR-139-5p/SETD5 Axis.

Journal: Technology in cancer research & treatment
Published: May 02, 2022

Mutational landscape of thymic epithelial tumors in a Chinese population: insights into potential clinical implications.

Mutational landscape of thymic epithelial tumors in a Chinese population: insights into potential clinical implications.

Journal: Gland surgery
Published: May 10, 2021

LINC01224/ZNF91 Promote Stem Cell-Like Properties and Drive Radioresistance in Non-Small Cell Lung Cancer.

LINC01224/ZNF91 Promote Stem Cell-Like Properties and Drive Radioresistance in Non-Small Cell Lung Cancer.

Journal: Cancer management and research
Published: March 31, 2021

Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin‑resistant non‑small cell lung cancer.

Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin‑resistant non‑small cell lung cancer.

Journal: International journal of oncology
Published: June 14, 2019

HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer.

HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer.

Journal: OncoTargets and therapy
Published: May 29, 2019

Epigenetic activation of hepatocyte growth factor is associated with epithelial-mesenchymal transition and clinical outcome in non-small cell lung cancer.

Epigenetic activation of hepatocyte growth factor is associated with epithelial-mesenchymal transition and clinical outcome in non-small cell lung cancer.

Journal: Journal of Cancer
Published: September 17, 2018

let‑7 and miR‑17 promote self‑renewal and drive gefitinib resistance in non‑small cell lung cancer.

let‑7 and miR‑17 promote self‑renewal and drive gefitinib resistance in non‑small cell lung cancer.

Journal: Oncology reports
Published: May 25, 2018

ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1.

ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1.

Journal: Scientific reports
Published: March 20, 2017

The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer.

The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer.

Journal: BMC cancer
Published: December 31, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026